Pharmanovia
Improving drugs for patients
- B2B
About Pharmanovia
Global healthcare company enhancing established medicines through rediscovery, repurposing, and re-engineering to improve patient outcomes in diverse therapeutic areas globally
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 251–1,000 employees
- Headquarters
- basildon, essex, United Kingdom
- Founded
- 2013
- Revenue
- $37.9M – $299MTamtam estimate
- Website
- pharmanovia.com
- linkedin.com/company/pharmanovia
Pharmanovia in the news
- IMPACT Therapeutics licenses Senaparib to Pharmanovia
IMPACT Therapeutics licensed exclusive rights for its drug senaparib to Pharmanovia for commercialization across 66 countries, focusing on ovarian cancer treatment.
- Eupraxia Pharma Partners with Pharmanovia to License Senaparib in 66 Countries Including EU; Shares Surge Over 12%
Eupraxia Pharma licensed its anti-cancer drug Senaparib to Pharmanovia for 66 countries, leading to a surge in Eupraxia Pharma's shares.
- Pharmanovia licenses China-approved PARP drug for up to €423.5M
Pharmanovia has licensed a China-approved PARP inhibitor drug for up to ․423.5M, expanding its oncology portfolio with a near-market ovarian cancer asset.
- IMPACT Therapeutics grants Pharmanovia exclusive $488m rights to senaparib
Pharmanovia secured exclusive licensing rights from IMPACT Therapeutics for senaparib, a cancer treatment, across 66 countries for nearly $488 million.
- Pharmanovia Announces Launch of Korjuny (Catumaxomab) in Germany, a First-in-class Treatment for Malignant Ascites
Germany has introduced catumaxomab as the first approved drug therapy for malignant ascites to improve the quality of life for advanced cancer patients.
Pharmanovia at a glance
Pharmanovia is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in basildon, essex, United Kingdom.
Pharmanovia was founded in 2013.
Pharmanovia has 251–1,000 employees.
Pharmanovia's revenue is $37.9M – $299M (Tamtam estimate).
Selling to companies like Pharmanovia?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies